Literature DB >> 24201334

Idiopathic pulmonary fibrosis.

Owen J Dempsey1, David Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24201334     DOI: 10.1136/bmj.f6579

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Apigenin protects against bleomycin-induced lung fibrosis in rats.

Authors:  Ling Chen; Wei Zhao
Journal:  Exp Ther Med       Date:  2015-11-20       Impact factor: 2.447

2.  Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/ angiotensin-(1-7) axis in rats.

Authors:  Huajie Wu; Yan Li; Yanxia Wang; Dunquan Xu; Congcong Li; Manling Liu; Xin Sun; Zhichao Li
Journal:  Int J Med Sci       Date:  2014-04-07       Impact factor: 3.738

3.  Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.

Authors:  Liang Xu; Wen-Hui Cui; Wen-Cheng Zhou; De-Lin Li; Liu-Cheng Li; Ping Zhao; Xiao-Ting Mo; Zhihui Zhang; Jian Gao
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

4.  Juglanin suppresses fibrosis and inflammation response caused by LPS in acute lung injury.

Authors:  Ze-Wu Dong; Yu-Fang Yuan
Journal:  Int J Mol Med       Date:  2018-03-09       Impact factor: 4.101

5.  Increased regional ventilation as early imaging marker for future disease progression of interstitial lung disease: a feasibility study.

Authors:  Sarah C Scharm; Cornelia Schaefer-Prokop; Moritz Willmann; Jens Vogel-Claussen; Lars Knudsen; Danny Jonigk; Jan Fuge; Tobias Welte; Frank Wacker; Antje Prasse; Hoen-Oh Shin
Journal:  Eur Radiol       Date:  2022-03-31       Impact factor: 7.034

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.